Double-blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate-to-severe relapses of multiple sclerosis.
Fiche publication
Date publication
mai 2020
Journal
Journal of clinical apheresis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme
Tous les auteurs :
Brochet B, Deloire M, Germain C, Ouallet JC, Wittkop L, Dulau C, Perez P, Thevenot F, De Sèze J, Zéphir H, Vermersch P, Pittion S, Debouverie M, Laplaud DA, Clavelou P, Ruet A
Lien Pubmed
Résumé
No randomized controlled clinical trial of therapeutic plasma exchanges (TPE) has yet been performed for moderate-to-severe relapses of multiple sclerosis (MS).
Mots clés
apheresis, central nervous system, clinical trial, demyelinating disease, disability, therapeutic plasma exchanges
Référence
J Clin Apher. 2020 May 5;: